SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001447028-19-000078
Filing Date
2019-12-23
Accepted
2019-12-20 20:24:23
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 s-3.htm S-3 574233
2 EXHIBIT 1.3 a13atmamend1tosa.htm EX-1.3 19660
3 EXHIBIT 4.3 a43formofindenture.htm EX-4.3 382244
4 EXHIBIT 5.1 a51farrisforms3opinionandc.htm EX-5.1 21114
5 EXHIBIT 5.2 a52farrisopinionreatmoffer.htm EX-5.2 11280
6 EXHIBIT 23.1 a231kpmgconsent.htm EX-23.1 7407
7 a51farrisforms3opinio_image1.gif GRAPHIC 817
8 a52farrisopinionreatm_image4.gif GRAPHIC 2174
9 a231kpmgconsentimage1.gif GRAPHIC 3665
10 abus02.jpg GRAPHIC 67159
11 abus05.jpg GRAPHIC 67159
12 abus07.jpg GRAPHIC 67159
13 abus08.jpg GRAPHIC 67159
  Complete submission text file 0001447028-19-000078.txt   1397270
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235674 | Film No.: 191303259
SIC: 2834 Pharmaceutical Preparations